| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1083-8791(03)00108-3 |
| P698 | PubMed publication ID | 12813443 |
| P2093 | author name string | John P Higgins | |
| Samuel Strober | |||
| Defu Zeng | |||
| Fengshuo Lan | |||
| Masanori Higuchi | |||
| P2860 | cites work | Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease | Q36368026 |
| Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers | Q36368804 | ||
| CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade | Q36369151 | ||
| CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes | Q36369438 | ||
| Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis | Q36369830 | ||
| Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation | Q36370863 | ||
| Natural Suppressor (NS) Cells, Neonatal Tolerance, and Total Lymphoid Irradiation: Exploring Obscure Relationships | Q40097097 | ||
| Mouse CD1-specific NK1 T cells: development, specificity, and function | Q41464349 | ||
| Comparison of chimeric acid and non-chimeric tolerance using posttransplant total lymphoid irradiation: cytokine expression and chronic rejection | Q41697921 | ||
| The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice | Q63363340 | ||
| Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells | Q74321466 | ||
| Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes | Q74455329 | ||
| Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies | Q77093417 | ||
| Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen | Q77958437 | ||
| Prevention of graft versus host disease by inactivation of host antigen-presenting cells | Q78016071 | ||
| The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality | Q78033315 | ||
| Total lymphoid irradiation nonmyeloablative preconditioning enriches for IL-4-producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+ cells | Q78447807 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 355-363 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | Biology of Blood and Marrow Transplantation | Q15754328 |
| P1476 | title | Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells | |
| P478 | volume | 9 |
| Q64056508 | Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease |
| Q81042784 | Adoptive transfer of small numbers of DX5+ cells alleviates graft-versus-host disease in a murine model of semiallogeneic bone marrow transplantation: a potential role for NKT lymphocytes |
| Q36988746 | Advancements in immune tolerance |
| Q35094374 | Biomarkers in chronic graft-versus-host disease |
| Q34551230 | CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells |
| Q92735571 | Combined kidney and hematopoeitic cell transplantation to induce mixed chimerism and tolerance |
| Q33884869 | DX5+NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1-Balb/c and NK1.1+ C57Bl/6 mice |
| Q35127172 | Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects |
| Q37378659 | Differences in Bcl-2 expression by T-cell subsets alter their balance after in vivo irradiation to favor CD4+Bcl-2hi NKT cells. |
| Q35553621 | Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation |
| Q38013047 | Emerging concepts in haematopoietic cell transplantation |
| Q37978779 | Emerging uses for pediatric hematopoietic stem cells |
| Q36863475 | Experimental and clinical approaches for optimization of the graft-versus-leukemia effect. |
| Q61657682 | Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation |
| Q36793622 | Graft-versus-host disease |
| Q80032701 | Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donors |
| Q89777152 | HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity |
| Q37176591 | Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease |
| Q37565143 | Human invariant natural killer T cells: implications for immunotherapy |
| Q38064621 | Immune tolerance and transplantation |
| Q36488762 | In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease |
| Q36838087 | Incidence and Pattern of Graft-versus-Host Disease in Patients Undergoing Allogeneic Transplantation after Nonmyeloablative Conditioning with Total Lymphoid Irradiation and Antithymocyte Globulin |
| Q52628809 | Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic bone marrow transplantation. |
| Q38616695 | Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation |
| Q38734173 | Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression. |
| Q34616147 | Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond |
| Q43432096 | Migration and chemokine receptor pattern of colitis-preventing DX5+NKT cells. |
| Q26765845 | NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment |
| Q34078681 | NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs. |
| Q37768104 | NKT cells, Treg, and their interactions in bone marrow transplantation |
| Q92707683 | Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort |
| Q37610711 | Nonmyeloablative conditioning with total lymphoid irradiation and antithymocyte globulin: an update |
| Q33734003 | Path to clinical transplantation tolerance and prevention of graft-versus-host disease |
| Q81442378 | Protecting the host naturally |
| Q37731525 | Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology |
| Q42793688 | Recipient myeloid-derived immunomodulatory cells induce PD-1 ligand-dependent donor CD4+Foxp3+ regulatory T cell proliferation and donor-recipient immune tolerance after murine nonmyeloablative bone marrow transplantation |
| Q36462109 | Regulatory T Cell Immunotherapy in Immune-Mediated Diseases |
| Q37272005 | Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation |
| Q58694412 | Regulatory immunotherapy in bone marrow transplantation |
| Q34381246 | Requirement for interactions of natural killer T cells and myeloid-derived suppressor cells for transplantation tolerance |
| Q36779768 | Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy |
| Q39114090 | Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation |
| Q38625892 | Selective resistance of CD44hi T cells to p53-dependent cell death results in persistence of immunologic memory after total body irradiation |
| Q37337098 | Stable mixed chimerism and tolerance to human organ transplants |
| Q37813013 | TBI during BM and SCT: review of the past, discussion of the present and consideration of future directions |
| Q37291642 | TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors |
| Q24648939 | The role of NKT cells in tumor immunity |
| Q35662003 | Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality |
| Q37894465 | Translational studies in hematopoietic cell transplantation: treatment of hematologic malignancies as a stepping stone to tolerance induction |
| Q91554792 | Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation |
| Q36930223 | iNKT cells require CCR4 to localize to the airways and to induce airway hyperreactivity. |
Search more.